Kimberly E. Fultz
Impact in
- Biochemistry top 10%
- Amino Acid Enzymes and Metabolism
-
- Inflammatory mediators and NSAID effects
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 6
- Epigenetics and DNA Methylation 2
- Melanoma and MAPK Pathways 2
- Protein Kinase Regulation and GTPase Signaling 2
- Polyamine Metabolism and Applications 2
- Oncology 5
- Colorectal Cancer Treatments and Studies 1
- Co-authors
- Eugene W. Gerner (3 shared papers)Naveen Babbar (1 shared paper)Hagit Yerushalmi (1 shared paper)Yongjun Guo (1 shared paper)Marı́a Elena Martı́nez (1 shared paper)Ning Qu (1 shared paper)David W. Boorman (1 shared paper)Janine G. Einspahr (1 shared paper)
- Journals
- European Journal of Cancer (5 papers)Journal of Medicinal Chemistry (2 papers)Molecular Carcinogenesis (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- United StatesSwitzerlandBrazil
In The Last Decade
Kimberly E. Fultz
15 papers receiving 357 citations
Peers
Comparison fields: 5 of 64
- Biochemistry 62
- Pharmacology 56
- Cancer Research 47
- Molecular Biology 230
- Oncology 79
Countries citing papers authored by Kimberly E. Fultz
This map shows the geographic impact of Kimberly E. Fultz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly E. Fultz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly E. Fultz more than expected).
Fields of papers citing papers by Kimberly E. Fultz
This network shows the impact of papers produced by Kimberly E. Fultz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly E. Fultz. The network helps show where Kimberly E. Fultz may publish in the future.
Co-authors
The 25 scholars most cited alongside Kimberly E. Fultz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 147 | |
| 2 | 2005 | 57 | |
| 3 | 2002 | 40 | |
| 4 | 2008 | 27 | |
| 5 | 2011 | 24 | |
| 6 | 2001 | 23 | |
| 7 | 2013 | 20 | |
| 8 | 2019 | 17 | |
| 9 | 2021 | 6 | |
| 10 | 2012 | 2 | |
| 11 | 2014 | 2 | |
| 12 | 2013 | 1 | |
| 13 | 2012 | 1 | |
| 14 | 2012 | 1 | |
| 15 | 2014 | 1 |
About Kimberly E. Fultz
Kimberly E. Fultz is a scholar working on Molecular Biology, Oncology, Pathology and Forensic Medicine, Biochemistry and Organic Chemistry, having authored 15 papers that have together received 369 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (6 papers), Cancer Mechanisms and Therapy (3 papers), Epigenetics and DNA Methylation (2 papers), Amino Acid Enzymes and Metabolism (2 papers), Melanoma and MAPK Pathways (2 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), Polyamine Metabolism and Applications (2 papers) and Colorectal Cancer Treatments and Studies (1 paper). The work is most often cited by research in Biochemistry (62 citations), Pharmacology (56 citations), Cancer Research (47 citations), Molecular Biology (230 citations) and Oncology (79 citations). Kimberly E. Fultz has collaborated with scholars based in United States, Switzerland and Brazil. Frequent co-authors include Eugene W. Gerner, Naveen Babbar, Hagit Yerushalmi, Yongjun Guo, Marı́a Elena Martı́nez, Ning Qu, David W. Boorman, Janine G. Einspahr, David S. Alberts and Thomas G. O’Brien. Their work appears in journals such as European Journal of Cancer, Journal of Medicinal Chemistry, Molecular Carcinogenesis, Bioorganic & Medicinal Chemistry Letters and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.